BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2…

BioRestorative Therapies, Inc. , a life sciences company focused on stem cell-based therapies, today announced that it has received clearance by the U.S. Food and Drug Administration to commence a Phase 2 clinical trial using its lead cell therapy candidate, BRTX-100, to treat chronic lower back pain due to degenerative disc disease related to protruding/bulging discs. The Phase 2 clinical trial is a 72 patient, randomized, double-blind, controlled, multi-center study designed to evaluate safety and efficacy of a single dose of BRTX-100 in treating chronic lower lumbar disc disease.

Important Investor Alert: Lundin Law PC Announces Securities Class…

Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Regulus Therapeutics Inc. . Investors who purchased or otherwise acquired Regulus shares between January 21, 2016 and June 27, 2016 inclusive , are encouraged to contact the firm in advance of the To participate in this class action lawsuit, click here .

Trump’s Hair Growth Medicine: What Is Finasteride?

Donald Trump’s personal doctor recently revealed that the president takes a handful of medications, including a daily aspirin to lower heart attack risk, an antibiotic to treat the skin condition rosacea, a statin to lower cholesterol – and a hair-loss drug called finasteride. The physician, Dr. Harold Bornstein, credited finasteride with helping maintain Trump’s head of hair, as well as his own long locks.

Health Highlights: Feb. 2, 2017

… of the greatest minds from around the world to maintain the high quality of our biomedical research enterprise and health care services,” they wrote. “Limiting the exchange of ideas, practices, and data across cultures has the potential to …

Merck 2017 forecast eases concerns over royalty payments, dollar

Merck & Co Inc reported better-than-expected U.S. quarterly sales for its key cancer drug, Keytruda, and forecast largely in-line 2017 results, which some analysts said allayed concerns over the impact of a strong dollar and royalty payments. The logo of Merck is pictured in this illustration photograph in Cardiff, California April 26, 2016.

Toxins in your fast-food packaging?

… Six of the samples also contained a long-chain PFOA, even though the chemical is no longer widely used because of health hazards. PFOA could be present in these wrappers because recycled paper was used in their manufacture, Schaider said — an …

NICO receives new clearance from FDA for brain surgery technology

The U.S. Food and Drug Administration in less than a 15-month period has granted a new and updated 510 clearance for two patented technologies made by NICO Corporation that are used in a new approach for brain surgery. Most recently, NICO received a new clearance for specific neurosurgical indications on its patented Myriad automated tissue removal technology.

European agency will review BioCryst’s flu drug

BioCryst Pharmaceuticals Inc., maker of the flu drug Rapivab, announced Monday that the European Medicines Agency will review its drug for the treatment of flu symptoms in adults. The London-based overseer of drugs sold in the European Union will issue a decision within 210 days on whether to allow the sale of Rapivab in the EU’s 28 member states and Norway and Iceland, a market of more than 500 million consumers.

Novartis Signals Growing Ambitions for CAR-T Cancer Treatments

Novartis AG is pushing ahead with one of its most ambitious cancer therapies, a treatment that the Swiss drugmaker says has blockbuster potential as it extends that technology to a wider pool of tumor-ridden patients. Europe’s second-biggest drugmaker is planning to test its CAR-T treatments — which involve extracting immune cells and genetically engineering them to hunt and kill cancer cells before returning them into the patient’s body — on lethal cancers of the brain, pancreas, colon, ovary and lung.

FDA warns against use of homeopathic teething products

The U.S. Food and Drug Administration said on Friday it has found high amounts of a toxic substance in homeopathic teething tablets, warning of its potential risk to infants and children. According to laboratory analysis by the health regulator, the amounts of belladonna, a toxic substance, sometimes far exceeded the amount claimed on the label of these teething tablets.

Latest Clinical Data from OncBioMune Supports Safety and Therapeutic…

In the ongoing Phase 1 clinical trial, ProscaVax is being evaluated for safety and efficacy in prostate specific antigen recurrent prostate cancer in hormone-naive and hormone-independent patients. Per protocol, 20 patients are expected to be enrolled in the 1a portion of the study, with therapy consisting of six ProscaVax induction vaccinations at a single dose.

Newer Hepatitis C Drugs May Pose Health Risks

Jan. 25, 2017 — Newer drugs to cure hepatitis C may put patients at risk for liver failure and other severe side effects, according to a new study from a U.S. nonprofit group that examines drug safety. The study by the Institute for Safe Medication Practices is based on an analysis of U.S. Food and Drug Administration data and reports from doctors worldwide on adverse events possibly caused by the nine widely used antiviral drugs, The New York Times reported.

Health Highlights: Jan. 25, 2017

Newer drugs to cure hepatitis C may put patients at risk for liver failure and other severe side effects, according to a new study from a U.S. nonprofit group that examines drug safety. The study by the Institute for Safe Medication Practices is based on an analysis of U.S. Food and Drug Administration data and reports from doctors worldwide on adverse events possibly caused by the nine widely used antiviral drugs, The New York Times reported.

‘Red Yeast Rice’ Statin Alternative Not Harmless

A natural cholesterol -lowering supplement called red yeast rice could pose the same health risks to users as statin drugs, a new study contends. Red yeast rice could increase risk of muscle injury or liver damage, Italian researchers reported after reviewing 13 years of patient data.

Supplements unproven to fight colds, flu

… including dietary supplements, mostly to stay well, according to a survey conducted by the National Center for Health Statistics. Americans spend almost $30.2 billion a year on complementary approaches, the survey says. “I think many people are …

3 Biotechs Likely to Be Acquired in 2017

The year is still young, but we’ve already seen acquisitions of Ariad and CoLucid . Which biotechs could be scooped up next in 2017? Here’s why Clovis Oncology The number of big companies battling to acquire Medivationin 2016 shows that the oncology space is hot.

Skin cancer cream linked to 5 dog deaths:FDA

Five dogs have died from exposure to a skin cancer cream prescribed for people, according to the U.S. Food and Drug Administration. Ingesting very small amounts of the drug — fluorouracil topical cream USP 5% — can sicken or kill family pets, said the FDA.